Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Corey

Showing results (101-110 of 222) with videos related to

Pageof 23
Sort By:
JBMR Plus|September 3, 2024
Sclerotic prostate cancer bone metastasis: woven bone lesions with a twistFelipe Eltit, Qiong Wang, Naomi Jung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 27, 2016
GRM1 is An Androgen-Regulated Gene and its Expression Correlates with Prostate Cancer Progression in Pre-Clinical ModelsMojgan Shourideh, Gissou Azabdaftari, Kristopher Attwood, et al.
The Prostate|January 22, 2013
Characterization of osteoblastic and osteolytic proteins in prostate cancer bone metastasesSandy R Larson, Xiaotun Zhang, Ruth Dumpit, et al.
Oncogene|March 2, 2019
A positive role of c-Myc in regulating androgen receptor and its splice variants in prostate cancerShanshan Bai, Subing Cao, Lianjin Jin, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 25, 2018
Systemic surfaceome profiling identifies target antigens for immune-based therapy in subtypes of advanced prostate cancerJohn K Lee, Nathanael J Bangayan, Timothy Chai, et al.
Oncogene|April 10, 2025
Correction: Novel inhibition of AKR1C3 and androgen receptor axis by PTUPB synergizes enzalutamide treatment in advanced prostate cancerJoy C Yang, Pengfei Xu, Shu Ning, et al.
Nature Communications|February 14, 2026
FOXJ1 mediates taxane resistance through regulation of microtubule dynamicsFang Xie, Ada Gjyrezi, Daniel Fein, et al.
Molecular Cancer Research : MCR|September 16, 2022
Subtype and Site Specific-Induced Metabolic Vulnerabilities in Prostate CancerFederica Mossa, Daniele Robesti, Ramachandran Sumankalai, et al.
Prostate Cancer and Prostatic Diseases|April 22, 2020
The expression of YAP1 is increased in high-grade prostatic adenocarcinoma but is reduced in neuroendocrine prostate cancerSiyuan Cheng, Nestor Prieto-Dominguez, Shu Yang, et al.
Nature Communications|July 10, 2021
Multiplexed functional genomic analysis of 5' untranslated region mutations across the spectrum of prostate cancerYiting Lim, Sonali Arora, Samantha L Schuster, et al.
Pageof 23

Showing results (101-110 of 222) with videos related to

Sort By:
Pageof 23
JBMR Plus|September 3, 2024
Sclerotic prostate cancer bone metastasis: woven bone lesions with a twistFelipe Eltit, Qiong Wang, Naomi Jung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 27, 2016
GRM1 is An Androgen-Regulated Gene and its Expression Correlates with Prostate Cancer Progression in Pre-Clinical ModelsMojgan Shourideh, Gissou Azabdaftari, Kristopher Attwood, et al.
The Prostate|January 22, 2013
Characterization of osteoblastic and osteolytic proteins in prostate cancer bone metastasesSandy R Larson, Xiaotun Zhang, Ruth Dumpit, et al.
Oncogene|March 2, 2019
A positive role of c-Myc in regulating androgen receptor and its splice variants in prostate cancerShanshan Bai, Subing Cao, Lianjin Jin, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 25, 2018
Systemic surfaceome profiling identifies target antigens for immune-based therapy in subtypes of advanced prostate cancerJohn K Lee, Nathanael J Bangayan, Timothy Chai, et al.
Oncogene|April 10, 2025
Correction: Novel inhibition of AKR1C3 and androgen receptor axis by PTUPB synergizes enzalutamide treatment in advanced prostate cancerJoy C Yang, Pengfei Xu, Shu Ning, et al.
Nature Communications|February 14, 2026
FOXJ1 mediates taxane resistance through regulation of microtubule dynamicsFang Xie, Ada Gjyrezi, Daniel Fein, et al.
Molecular Cancer Research : MCR|September 16, 2022
Subtype and Site Specific-Induced Metabolic Vulnerabilities in Prostate CancerFederica Mossa, Daniele Robesti, Ramachandran Sumankalai, et al.
Prostate Cancer and Prostatic Diseases|April 22, 2020
The expression of YAP1 is increased in high-grade prostatic adenocarcinoma but is reduced in neuroendocrine prostate cancerSiyuan Cheng, Nestor Prieto-Dominguez, Shu Yang, et al.
Nature Communications|July 10, 2021
Multiplexed functional genomic analysis of 5' untranslated region mutations across the spectrum of prostate cancerYiting Lim, Sonali Arora, Samantha L Schuster, et al.
Pageof 23